Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Lower SHBG levels may increase the risk of PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

High androgen levels often cause female hirsutism and infertility.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Low SHBG levels are linked to negative health outcomes and should be used in assessing and managing health conditions.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Lower testosterone levels may increase heart failure risk in older men.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Norplant implants lower some androgen levels but don't significantly change sexual function.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.